stock.name

Pacira BioSciences Inc

PCRX

Market Cap$1.41B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Pacira BioSciences IncPacira BioSciences Inc200%8%2.20.6
$42.00

Target Price by Analysts

37.9% upsidePacira BioSciences Target Price DetailsTarget Price
$68.33

Current Fair Value

124.3% upside

Undervalued by 124.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.41 Billion
Enterprise Value$1.61 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$1.32
Beta0.5
Outstanding Shares46,546,148
Avg 30 Day Volume996,056

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio20.03
PEG-13.72
Price to Sales2.18
Price to Book Ratio1.6
Enterprise Value to Revenue2.36
Enterprise Value to EBIT17.19
Enterprise Value to Net Income22
Total Debt to Enterprise0.32
Debt to Equity0.58

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Pacira BioSciences Inc